Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 285

The DOI matches its Crossref record; 98 of the 98 references it cites were found in a registry or an index.

Considerations for improving assay sensitivity in chronic pain clinical trials: IMMPACT recommendations

Dworkin, Robert H., Turk, Dennis C., Peirce-Sandner, Sarah, Burke, Laurie B., Farrar, John T., Gilron, Ian, Jensen, Mark P., Katz, Nathaniel P., Raja, Srinivasa N., Rappaport, Bob A., Rowbotham, Michael C., Backonja, Misha-Miroslav, Baron, Ralf, Bellamy, Nicholas, Bhagwagar, Zubin, Costello, Ann, Cowan, Penney, Fang, Weikai Christopher, Hertz, Sharon, Jay, Gary W., Junor, Roderick, Kerns, Robert D., Kerwin, Rosemary, Kopecky, Ernest A., Lissin, Dmitri, Malamut, Richard, Markman, John D., McDermott, Michael P., Munera, Catherine, Porter, Linda, Rauschkolb, Christine, Rice, Andrew S.C., Sampaio, Cristina, Skljarevski, Vladimir, Sommerville, Kenneth, Stacey, Brett R., Steigerwald, Ilona, Tobias, Jeffrey, Trentacosti, Ann Marie, Wasan, Ajay D., Wells, George A., Williams, Jim, Witter, James, Ziegler, Dan·2012·Pain

Abstract

A number of pharmacologic treatments examined in recent randomized clinical trials (RCTs) have failed to show statistically significant superiority to placebo in conditions in which their efficacy had previously been demonstrated. Assuming the validity of previous evidence of efficacy and the comparability of the patients and outcome measures in these studies, such results may be a consequence of limitations in the ability of these RCTs to demonstrate the benefits of efficacious analgesic treatments vs placebo ("assay sensitivity"). Efforts to improve the assay sensitivity of analgesic trials could reduce the rate of falsely negative trials of efficacious medications and improve the efficiency of analgesic drug development. Therefore, an Initiative on Methods, Measurement, and Pain Assessment in Clinical Trials consensus meeting was convened in which the assay sensitivity of chronic pain trials was reviewed and discussed. On the basis of this meeting and subsequent discussions, the authors recommend consideration of a number of patient, study design, study site, and outcome measurement factors that have the potential to affect the assay sensitivity of RCTs of chronic pain treatments. Increased attention to and research on methodological aspects of clinical trials and their relationships with assay sensitivity have the potential to provide the foundation for an evidence-based approach to the design of analgesic clinical trials and expedite the identification of analgesic treatments with improved efficacy and safety.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.pain.2012.03.003

Cites

98 of 98 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 98 references

Cited by

See all 285

Metadata

Authors
Dworkin, R. H., Turk, D. C., Peirce-Sandner, S., Burke, L. B., Farrar, J. T., Gilron, I., Jensen, M. P., Katz, N. P., Raja, S. N., Rappaport, B. A., Rowbotham, M. C., Backonja, M.-M., Baron, R., Bellamy, N., Bhagwagar, Z., Costello, A., Cowan, P., Fang, W. C., Hertz, S., Jay, G. W., Junor, R., Kerns, R. D., Kerwin, R., Kopecky, E. A., Lissin, D., Malamut, R., Markman, J. D., McDermott, M. P., Munera, C., Porter, L., Rauschkolb, C., Rice, A. S. C., Sampaio, C., Skljarevski, V., Sommerville, K., Stacey, B. R., Steigerwald, I., Tobias, J., Trentacosti, A. M., Wasan, A. D., Wells, G. A., Williams, J., Witter, J., & Ziegler, D.
Venue
Pain
Published
2012-06
Volume
153
Issue
6
Pages
1148-1158
ISSN
0304-3959 (ISSN-L)
OpenAlex
W2005540257
Cited by
285
References
98
FWCI
25.17
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Considerations for improving assay sensitivity in chronic pain clinical trials: IMMPACT recommendations. https://app.cochat.ai/papers/10.1016/j.pain.2012.03.003
The paper
Dworkin, R. H., Turk, D. C., Peirce-Sandner, S., Burke, L. B., Farrar, J. T., Gilron, I., Jensen, M. P., Katz, N. P., Raja, S. N., Rappaport, B. A., Rowbotham, M. C., Backonja, M.-M., Baron, R., Bellamy, N., Bhagwagar, Z., Costello, A., Cowan, P., Fang, W. C., Hertz, S., . . . Ziegler, D. (2012). Considerations for improving assay sensitivity in chronic pain clinical trials: IMMPACT recommendations. Pain. https://doi.org/10.1016/j.pain.2012.03.003

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.